Bereich
Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin
AIM · Dept. I
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Wyss N, Berner F, Walter V, Jochum A, Purde M, Abdou M, Sinnberg T, Hofmeister K, Pop O, Hasan A, Bauer J, Cheng H, Lütge M, Klümper N, Diem S, Kosaloglu-Yalcin Z, Zhang Y, Sellmer L, Macek B, Karbach J, König D, Läubli H, Zender L, Meyer B, Driessen C, Schürch C, Jochum W, Amaral T, Heinzerling L, Cozzio A, Hegazy A, Schneider T, Brutsche M, Sette A, Lenz T, Walz J, Rammensee H, Früh M, Jäger E, Becher B, Tufman A, Núñez N, Jörger M, Flatz L. Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade. Am J Respir Crit Care Med 2024; 210:919-930.
01.10.2024Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
01.10.2024Am J Respir Crit Care Med 2024; 210:919-930
Wyss Nina, Berner Fiamma, Walter Vincent, Jochum Ann-Kristin, Purde Mette T, Abdou Marie-Therese, Sinnberg Tobias, Hofmeister Kathrin, Pop Oltin, Hasan Ali, Bauer Jens, Cheng Hung-Wei, Lütge Mechthild, Klümper Niklas, Diem Stefan, Kosaloglu-Yalcin Zeynep, Zhang Yizheng, Sellmer Laura, Macek Boris, Karbach Julia, König David, Läubli Heinz, Zender Lars, Meyer Britta S, Driessen Christoph, Schürch Christian M, Jochum Wolfram, Amaral Teresa, Heinzerling Lucie M, Cozzio Antonio, Hegazy AhN, Schneider Tino, Brutsche Martin, Sette Alessandro, Lenz Tobias L, Walz Juliane Sarah, Rammensee Hans-Georg, Früh Martin, Jäger Elke, Becher Burkhard, Tufman Amanda, Núñez Nicolás Gonzalo, Jörger Markus, Flatz Lukas
Healthcare‑associated infections in intensive care unit patients with and without COVID-19: a single center prospective surveillance study.
Bloch N, Rüfenacht S, Ludwinek M, Frick W, Kleger G, Schneider F, Albrich W, Flury D, Kuster S, Schlegel M, Kohler P. Healthcare‑associated infections in intensive care unit patients with and without COVID-19: a single center prospective surveillance study. Antimicrob Resist Infect Control 2023; 12:147.
18.12.2023Healthcare‑associated infections in intensive care unit patients with and without COVID-19: a single center prospective surveillance study.
18.12.2023Antimicrob Resist Infect Control 2023; 12:147
Bloch Nando, Rüfenacht Susanne, Ludwinek Magdalena, Frick Waldemar, Kleger Gian-Reto, Schneider Florian, Albrich Werner, Flury Domenica, Kuster Stefan, Schlegel Matthias, Kohler Philipp
Pulmonary and Systemic Hemodynamics in Patients with Hyperthyroidism.
Brenner R, Drescher T, Locher R, Bilz S, Rickli H, Brändle M, Nobel D, Weilenmann D, Ammann P, Maeder M. Pulmonary and Systemic Hemodynamics in Patients with Hyperthyroidism. Am J Med 2023
15.12.2023Pulmonary and Systemic Hemodynamics in Patients with Hyperthyroidism.
15.12.2023Am J Med 2023
Brenner Roman, Drescher Tilman, Locher Rebecca, Bilz Stefan, Rickli Hans, Brändle Michael, Nobel Daniel, Weilenmann Daniel, Ammann Peter, Maeder Micha
Effective infection prevention and control measures in long-term care facilities in non-outbreak and outbreak settings: a systematic literature review.
Bloch N, Männer J, Gardiol C, Kohler P, Kuhn J, Münzer T, Schlegel M, Kuster S, Flury D. Effective infection prevention and control measures in long-term care facilities in non-outbreak and outbreak settings: a systematic literature review. Antimicrob Resist Infect Control 2023; 12:113.
18.10.2023Effective infection prevention and control measures in long-term care facilities in non-outbreak and outbreak settings: a systematic literature review.
18.10.2023Antimicrob Resist Infect Control 2023; 12:113
Bloch Nando, Männer Jasmin, Gardiol Céline, Kohler Philipp, Kuhn Jacqueline, Münzer Thomas, Schlegel Matthias, Kuster Stefan, Flury Domenica
An estimation of the consequences of reinforcing the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society guidelines on current lipid-lowering treatment in patients with type 2 diabetes in tertiary care-a SwissDiab study.
Singeisen H, Renström F, Laimer M, Lehmann R, Bilz S, Brändle M. An estimation of the consequences of reinforcing the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society guidelines on current lipid-lowering treatment in patients with type 2 diabetes in tertiary care-a SwissDiab study. Eur J Prev Cardiol 2023; 30:1473-1481.
10.10.2023An estimation of the consequences of reinforcing the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society guidelines on current lipid-lowering treatment in patients with type 2 diabetes in tertiary care-a SwissDiab study.
10.10.2023Eur J Prev Cardiol 2023; 30:1473-1481
Singeisen Hélène, Renström Frida, Laimer Markus, Lehmann Roger, Bilz Stefan, Brändle Michael
ECG left ventricular hypertrophy in aortic stenosis: Relationship with cardiac structure, invasive hemodynamics, and long-term mortality.
Sager P, Rusch A, Weber L, Breuss A, Appert S, Brenner R, Buser M, Ammann P, Rickli H, Maeder M. ECG left ventricular hypertrophy in aortic stenosis: Relationship with cardiac structure, invasive hemodynamics, and long-term mortality. Clin Cardiol 2023; 47:e24155.
23.09.2023ECG left ventricular hypertrophy in aortic stenosis: Relationship with cardiac structure, invasive hemodynamics, and long-term mortality.
23.09.2023Clin Cardiol 2023; 47:e24155
Sager Patrizia, Rusch Andreas, Weber Lukas, Breuss Alexander, Appert Sharon, Brenner Roman, Buser Marc, Ammann Peter, Rickli Hans, Maeder Micha
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht L, Shannan B, Brase J, Gusenleitner D, Amaral T, Wyss N, Utikal J, Flatz L, Rambow F, Reinhardt H, Dick J, Engel D, Horn S, Ugurel S, Sondermann W, Livingstone E, Sucker A, Paschen A, Zhao F, Placke J, Klose J, Fendler W, Thommen D, Helfrich I, Schadendorf D, Roesch A. Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Nat Cancer 2023; 4:1395.
01.09.2023Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
01.09.2023Nat Cancer 2023; 4:1395
Váraljai Renáta, Zimmer Lisa, Al-Matary Yahya, Kaptein Paulien, Albrecht Lea J, Shannan Batool, Brase Jan C, Gusenleitner Daniel, Amaral Teresa, Wyss Nina, Utikal Jochen, Flatz Lukas, Rambow Florian, Reinhardt Hans Christian, Dick Jenny, Engel Daniel R, Horn Susanne, Ugurel Selma, Sondermann Wiebke, Livingstone Elisabeth, Sucker Antje, Paschen Annette, Zhao Fang, Placke Jan M, Klose Jasmin M, Fendler Wolfgang Peter, Thommen Daniela S, Helfrich Iris, Schadendorf Dirk, Roesch Alexander
Pseudohypoglykämie bei systemischer Sklerose
Broder S. Pseudohypoglykämie bei systemischer Sklerose - Irreführende Blutzuckerwerte. Swiss Medcial Forum 2023; 23:1254-1255.
24.08.2023Pseudohypoglykämie bei systemischer Sklerose
24.08.2023Swiss Medcial Forum 2023; 23:1254-1255
Broder Simon
STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
Woelfel S, Dütschler J, König M, Dulovic A, Graf N, Junker D, Oikonomou V, Krieger-Grübel C, Truniger S, Franke A, Eckhold A, Forsch K, Koller S, Wyss J, Krupka N, Oberholzer M, Frei N, Geissler N, Schaub P, STAR SIGN Study Investigators, Albrich W, Friedrich M, Schneiderhan-Marra N, Misselwitz B, Korte W, Bürgi J, Brand S. STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2023; 58:678-691.
12.08.2023STAR SIGN study: Evaluation of COVID-19 vaccine efficacy against the SARS-CoV-2 variants BQ.1.1 and XBB.1.5 in patients with inflammatory bowel disease.
12.08.2023Aliment Pharmacol Ther 2023; 58:678-691
Woelfel Simon, Dütschler Joel, König Marius, Dulovic Alex, Graf Nicole, Junker Daniel, Oikonomou Vasileios, Krieger-Grübel Claudia, Truniger Samuel, Franke Annett, Eckhold Annika, Forsch Kristina, Koller Seraina, Wyss Jacqueline, Krupka Niklas, Oberholzer Melanie, Frei Nicola Fabian, Geissler Nora, Schaub Peter, STAR SIGN Study Investigators, Albrich Werner, Friedrich Matthias, Schneiderhan-Marra Nicole, Misselwitz Benjamin, Korte Wolfgang C, Bürgi Justus J, Brand Stephan
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht L, Shannan B, Brase J, Gusenleitner D, Amaral T, Wyss N, Utikal J, Flatz L, Rambow F, Reinhardt H, Dick J, Engel D, Horn S, Ugurel S, Sondermann W, Livingstone E, Sucker A, Paschen A, Zhao F, Placke J, Klose J, Fendler W, Thommen D, Helfrich I, Schadendorf D, Roesch A. Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Nat Cancer 2023; 4:1292-1308.
31.07.2023Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
31.07.2023Nat Cancer 2023; 4:1292-1308
Váraljai Renáta, Zimmer Lisa, Al-Matary Yahya, Kaptein Paulien, Albrecht Lea J, Shannan Batool, Brase Jan C, Gusenleitner Daniel, Amaral Teresa, Wyss Nina, Utikal Jochen, Flatz Lukas, Rambow Florian, Reinhardt Hans Christian, Dick Jenny, Engel Daniel R, Horn Susanne, Ugurel Selma, Sondermann Wiebke, Livingstone Elisabeth, Sucker Antje, Paschen Annette, Zhao Fang, Placke Jan M, Klose Jasmin M, Fendler Wolfgang Peter, Thommen Daniela S, Helfrich Iris, Schadendorf Dirk, Roesch Alexander
CME: Ambulantes Management von Patientinnen und Patienten mit Leberzirrhose
Deuschle F, Semela D, Henz S. CME: Ambulantes Management von Patientinnen und Patienten mit Leberzirrhose. Praxis (Bern 1994) 2023; 112:373-380-380.
07.06.2023CME: Ambulantes Management von Patientinnen und Patienten mit Leberzirrhose
07.06.2023Praxis (Bern 1994) 2023; 112:373-380-380
Deuschle Florian, Semela David, Henz Samuel
[Electrical Accidents].
Hörburger D, Schmidt E, Henz S. [Electrical Accidents]. Praxis (Bern 1994) 2023; 112:426-430.
01.06.2023[Electrical Accidents].
01.06.2023Praxis (Bern 1994) 2023; 112:426-430
Hörburger David, Schmidt Elke, Henz Samuel
A rare cause of B symptoms
Wassmer P (2023). A rare cause of B symptoms.
10.05.2023A rare cause of B symptoms
10.05.2023SGAIM Frühjahrskongress 2023
Wassmer Philipp
Severe Pancytopenia induced by Metamizole
Spasojevic N, Tobler M, Fehr M, Henz S (2023). Severe Pancytopenia induced by Metamizole.
10.05.2023Severe Pancytopenia induced by Metamizole
10.05.2023SGAIM Frühjahrskonferenz
Spasojevic Natalija, Tobler Micaela, Fehr Martin, Henz Samuel
Amoebiasis presenting as colitis and complicated appendicitis
Grimm S, Henz S (2023). Amoebiasis presenting as colitis and complicated appendicitis .
10.05.2023Amoebiasis presenting as colitis and complicated appendicitis
10.05.2023SGAIM Frühjahrskonferenz
Grimm Sarah, Henz Samuel
Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay.
Jaun F, Boesing M, Lüthi-Corridori G, Abig K, Bloch N, Giezendanner S, Grillmayr V, Haas P, Leuppi-Taegtmeyer A, Muser J, Räss A, Schuetz P, Brändle M, Leuppi J. Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay. Biomedicines 2023; 11
25.04.2023Effect of Single High Dose Vitamin D Substitution in Hospitalized COVID-19 Patients with Vitamin D Deficiency on Length of Hospital Stay.
25.04.2023Biomedicines 2023; 11
Jaun Fabienne, Boesing Maria, Lüthi-Corridori Giorgia, Abig Kristin, Bloch Nando, Giezendanner Stéphanie, Grillmayr Victoria, Haas Philippe, Leuppi-Taegtmeyer Anne Barbara, Muser Jürgen, Räss Andrea, Schuetz Philipp, Brändle Michael, Leuppi Joerg Daniel
Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland: A health-economic analysis.
Tzogiou C, Wieser S, Eichler K, Carlander M, Djalali S, Rosemann T, Brändle M. Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland: A health-economic analysis. J Diabetes Complications 2023; 37:108476.
23.04.2023Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland: A health-economic analysis.
23.04.2023J Diabetes Complications 2023; 37:108476
Tzogiou Christina, Wieser Simon, Eichler Klaus, Carlander Maria, Djalali Sima, Rosemann Thomas, Brändle Michael
Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial.
Komminoth M, Donath M, Hepprich M, Schuetz P, Blum C, Müller-Stich B, Reny J, Gosselin P, Breville G, Brändle M, Henzen C, Leuppi J, Kistler A, Thurnheer R, Beuschlein F, Rudofsky G, Aeberli D, Villiger P, Böhm S, Chifu I, Fassnacht M, Meyer G, Bojunga J, Cattaneo M, Sluka C, Schneider H, Rutishauser J, «TOASST» study group. Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial. PloS one 2023; 18:e0281585.
05.04.2023Glucocorticoid withdrawal and glucocorticoid-induced adrenal insufficiency: Study protocol of the randomized controlled «TOASST" (Taper Or Abrupt Steroid STop) multicenter trial.
05.04.2023PloS one 2023; 18:e0281585
Komminoth Mathis, Donath Marc Y, Hepprich Matthias, Schuetz Philipp, Blum Claudine A, Müller-Stich Beat P, Reny Jean-Luc, Gosselin Pauline, Breville Gautier, Brändle Michael, Henzen Christophe, Leuppi Joerg Daniel, Kistler Andreas D, Thurnheer Robert, Beuschlein Felix, Rudofsky Gottfried, Aeberli Daniel, Villiger Peter M, Böhm Stephan, Chifu Irina, Fassnacht Martin, Meyer Gesine, Bojunga Jörg, Cattaneo Marco, Sluka Constantin, Schneider Helga, Rutishauser Jonas, «TOASST» study group
Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023).
Gastaldi G, Lucchini B, Thalmann S, Alder S, Laimer M, Brändle M, Wiesli P, Lehmann R, Working group of the SGED/SSED. Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023). Swiss Med Wkly 2023; 153:40060.
01.04.2023Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023).
01.04.2023Swiss Med Wkly 2023; 153:40060
Gastaldi Giacomo, Lucchini Barbara Stella, Thalmann Sebastien, Alder Stephanie, Laimer Markus, Brändle Michael, Wiesli Peter, Lehmann Roger, Working group of the SGED/SSED
Reset of Inflammatory Priming of Joint Tissue and Reduction of the Severity of Arthritis Flares by Bromodomain Inhibition.
Friščić J, Reinwald C, Böttcher M, Houtman M, Euler M, Chen X, Walker K, Kirchner P, Zhu H, Wirth B, Weidner D, Krüger R, Trajkovic V, Ekici A, Klein K, Mougiakakos D, Ospelt C, Schett G, Hoffmann M. Reset of Inflammatory Priming of Joint Tissue and Reduction of the Severity of Arthritis Flares by Bromodomain Inhibition. Arthritis Rheumatol 2023; 75:517-532.
02.02.2023Reset of Inflammatory Priming of Joint Tissue and Reduction of the Severity of Arthritis Flares by Bromodomain Inhibition.
02.02.2023Arthritis Rheumatol 2023; 75:517-532
Friščić Jasna, Reinwald Christiane, Böttcher Martin, Houtman Miranda, Euler Maximilien, Chen Xiang, Walker Kellie I, Kirchner Philipp, Zhu Honglin, Wirth Benjamin, Weidner Daniela, Krüger René, Trajkovic Vladimir, Ekici Arif B, Klein Kerstin, Mougiakakos Dimitrios, Ospelt Caroline, Schett Georg, Hoffmann Markus H